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Zanvil Alexander Cohn, an editor of this Journal since 1973, died suddenly on June 28, 
1993. Cohn is best known as the father of the current era of macrophage biology. Many 
of his scientific accomplishments are recounted here, beginning with seminal studies on 
the granules of phagocytes that were performed with his close colleague and former editor 
of thisJournaI, James Hirsch. Cohn and Hirsch identified the granules as lysosomes that 
discharged their contents of digestive enzymes into vacuoles containing phagocytosed 
microbes.  These findings were part of the formative era of cell biology and initiated the 
modern study of endocytosis and cell-mediated resistance to infection. Cohn further ex- 
plored the endocytic apparatus in pioneering studies of the mouse peritoneal macrophage 
in culture. He described  vesicular inputs from the cell surface and Golgi apparatus and 
documented the thoroughness of substrate digestion within lysosomal vacuoles that would 
only permit the egress  of monosaccharides and amino acids. These discoveries created 
a vigorous environment for graduate students, postdoctoral  fellows, and junior and visiting 
faculty. Some of the major findings that emerged from Cohn's collaborations included 
the radioiodination of the plasma membrane for studies of composition and turnover; 
membrane recycling during endocytosis;  the origin of the mononuclear phagocyte system 
in situ; the discovery of the dendritic cell system of antigen-presenting cells; the macro- 
phage  as  a  secretory  cell,  including  the  release  of proteases  and  large  amounts  of 
prostaglandins and leukotrienes;  several defined parameters  of macrophage  activation, 
especially the ability of T  cell-derived lymphokines to enhance killing of tumor cells 
and intracellular protozoa; the granule discharge mechanism whereby cytotoxic lympho- 
cytes release the pore-forming protein perforin; the signaling of macrophages via myristoy- 
lated substrates of protein kinase C; and a tissue culture model in which monocytes emi- 
grate across tight endothelial junctions. In 1983, Cohn turned to a long-standing goal 
of exploring host resistance directly in humans. He studied leprosy, focusing on the dis- 
ease site, the parasitized macrophages of the skin. He injected recombinant lymphokines 
into the skin and found that these molecules elicited several cell-mediated responses. Seeing 
this potential to enhance host defense in patients, Cohn was extending his clinical studies 
to AIDS and tuberculosis. Zanvil Cohn was a consummate physician-scientist who nur- 
tured the relationship between cell biology and infectious disease. He guided with a warm 
but incisive manner the careers of many individuals. He was deeply committed to several 
institutions of biomedical research;  to medicine in the developing world; to The Rock- 
efeller University, especially its programs for graduate  study and patient-oriented research; 
and to the energy and spirit of this Journal. A  THbute 
Zanvil Alexander Cohn,  1926-1993 
T 
his  is  the  first  volume  since  1973  for  which  Zanvil 
Cohn has not served as an editor of The Journal of Ex- 
perimental Medicine. Zan died suddenly on June 28, 1993. He 
gave the  Journal years of leadership and energy, and his unique 
style enlivened our weekly deliberations. His incisive manner, 
his admiration of clever new experiments,  his  sense of fair- 
ness and respect, and his wit all will be sorely missed. A re- 
view of his  scientific contributions  and the environment in 
which these came about, some feelings about the man,  in- 
cluding his love for this Journal, and a complete bibliography 
seem a fitting  tribute  to our friend  and colleague. 
Recruitment to Infectious Diseases 
and to Phagocytes 
A devotion to infectious diseases  came quickly to Zan at 
Harvard Medical School. Prior to starting  the curriculum, 
he spent a year in the Department of Microbiology. He then 
continued to do independent laboratory work and produced 
a thesis entitled "A Biochemical Study of the Interaction of 
the Influenza A Virus and the Chorioallantoic Membrane of 
the Hefts Egg" The work was supervised by Monroe D. Eaton 
and Boris Magasanik,  and led to his first publication (1). In 
the introduction  to his thesis, Zan announced what would 
be a life-long scientific interest,  the host-parasite  relation- 
ship.  Zafts M.D.  degree in  1953  was one of a very few to 
be awarded summa cure laude in the history of Harvard Med- 
ical School. 
Zan trained in medicine from  1953  to  1955  at the Mas- 
sachusetts General Hospital. From 1955 to 1957, he met his 
military obligations, rising to Chief of the Division of Rick- 
ettsial Biology, Walter Reed Army Institute, and Captain in 
the Army Medical Corps. In the laboratory of  Joseph Smadel, 
Zan explored several topics with rickettsiae  that  were pre- 
scient of his  subsequent work (2-5,  8),  with emphasis  on 
respiratory enzymes, the microbial cell wall, and the penetra- 
tion  of Rickettsia  tsutsugamushi into  a mammalian  cell line 
in vitro (5). The latter was the first of Zan's  128 contribu- 
tions  to the Journal. 
Either in medical school or during his postgraduate training, 
Zan developed his intense admiration of Ren~ Dubos of The 
Rockefeller Institute  for Medical Research.  Dubos was an 
eminent  microbiologist who emphasized  the host-parasite 
interplay,  the microenvironment  of inflammation,  and the 
need for new therapies that would enhance host defense. Zan 
heard  Dubos's  Warren  Triennial  Lecture  at  Massachusetts 
General in 1953, which was incorporated in his monograph 
Biochemical Determinants of Microbial Diseases (1954, Harvard 
University Press).  After the lecture, Zan approached Dubos 
for a position at the Rockefeller. This was eventually granted, 
although  Dubos urged Zan not  to work on viruses! 
In 1957, Zanjoined Dubos's laboratory, which was affiliated 
with The Rockefeller Hospital. James Hirsch was part of the 
team and was fully engaged in studies of phagocytes in vitro. 
In 1960, Hirsch became professor and organized a new Labo- 
ratory of Cellular Immunology. Zan, Stephen Morse, and Louis 
Siltzbach were the first members of the new lab. Cohn par- 
ticipated in the lab's clinical  studies in the Hospital on sar- 
coidosis (14,  15, 44) that standardized the use of the Kveim 
reagent  in  the diagnosis  of this  disease. 
Dubos and Hirsch, themselves former editors of this  Journal, 
must have had a substantial influence on Zafts style. All three 
had a similar dedication to the broad reaches of the host-para- 
site interplay.  All three coupled a seriousness of scientific pur- 
pose and a high regard for experimentation  with an affable 
and sometimes skeptical manner.  All three had a real opti- 
mism tempered by a respect for the unknown. 
Zan began his  studies of the phagocyte-microbe interac- 
tion with Morse (6, 9, 10). They utilized Hirsch's methods 
for obtaining homogeneous populations of neutrophils in large 
numbers, especially glycogen-elicited, rabbit peritoneal exu- 
dates. Cohn and Morse adapted methods of Ole Maalce to 
segregate the two phases of white cell resistance,  ingestion 
and killing.  Neither phase was readily amenable to analysis 
in vivo since the white cell populations were mixed, blood 
and tissue fluids could have complicating effects, and quanti- 
tation was difficult. Cohn and Morse were able to separate 
cells from nonbound organisms in vitro and thereby to quan- 
titate ingestion  and killing.  They observed the  three basic 
outcomes: phagocytosis with killing (Staphylococcus  albus, Esch- 
erichia coli, and certain streptococci),  phagocytosis without 
killing (Mycobacterium smegmatis), and no phagocytosis at all 
(S. aureus and group A streptococci). Glycolysis was critical, 
as were serum opsonins in the case orS. aureus. Lipopolysac- 
charide (LPS) or endotoxin increased phagocytic activity. The 
approach taken by Morse and Cohn, the quantitative and di- 
rect study of the phagocyte-microbe interaction in vitro, was 
to bear fruit  quickly. 
Phagocyte Granules Are Lysosomes That 
Degranulate and Digest Microbes 
Cohn and Hirsch, focusing on events after ingestion,  ap- 
proached the most striking morphologic feature of the poly- 
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Three historic papers appeared together in The  Journal of  Ex- 
perimental Medicine (11-13). Using the techniques that were 
being pioneered by Albert Claude, Christian de Duve, and 
George Palade at The Rockefeller Institute, Zan and Jim were 
able to isolate  a morphologically homogeneous population 
of granules by differential centrifugation (11) (Fig.  1). They 
wrote that "the efficient but relatively nontraumatic disrup- 
tion" of the polys in cold 0.34 M sucrose was key, and they 
used the classic combination of high specific activity and 
recovery to establish  that the granules were the location for 
a group of hydrolytic enzymes active at low pH. They showed 
that the acid hydrolases  exhibited "latency,"  requiring dis- 
ruption by freezing and thawing for activity,  and they ob- 
served  the limiting membrane of the granules by electron 
microscopy. So the granules of the phagocyte, an object of 
tinctorial delight for decades, were now a biochemical and 
cell biological entity, identical to the lysosomes described by 
de Duve and colleagues. 
Hirsch and Cohn next worked out methods that proved 
that polys degranulated during phagocytosis (12). By first ap- 
plying the leukocytes to a surface, and then applying the or- 
ganisms, they observed that degranulation took place only 
in cells that had ingested organisms (Fig. 2). To visualize de- 
granulation more vividly, Hirsch produced elegant films of 
live phagocytes. These films, which remain an ideal compo- 
nent for many courses  in biology, allowed Zan and Jim to 
propose that granule lysis played a key role in the destruction 
of microorganisms. Cohn and Hirsch then used cell fraction- 
ation to solidify the notion of granule discharge (13). They 
found that in phagocytosing populations, a large proportion 
of the acid hydrolases moved from a pellet fraction to a soluble 
fraction. Later (see below) they realized that this "solubiliza- 
tion" was a manifestation of lysosome-phagosome fusion. 
Figure  1.  A representative  field  taken  from a sectioned  granule  pellet 
shows lysosomes  enriched  from neutrophils, x23,000 (11, Fig. 1). 
Figure 2.  Degranulation  of polymorphonuclear  leukocytes  during  pha- 
gocytosis.  Note the loss of cytoplasmic  granules  in two rabbit white  cells 
that have  ingested  chains  of  streptococci  (arrows),  and the presence  of  granules 
in a cell that has not phagocytosed  organisms  (arrowhead). xl,080 (12, 
Fig. 1 c). 
Zan took a biochemical approach to extend the concepts 
of granules as lysosomes that discharged and digested mi- 
crobes during phagocytosis. He radiolabeled the nucleic acids 
and proteins of bacteria  with 32p and 14C, respectively. He 
found that ingested organisms first lost their pools of acid- 
soluble metabolites and, within three hours, 70% of the acid- 
insoluble constituents were converted to TCA-soluble prod- 
ucts (22).  Once the organisms were internalized, a variety 
of metabolic inhibitors could not slow digestion (23). 
Then,  with  Edith Wiener,  a postdoctoral fellow  from 
Jerusalem, Zan isolated the particulate hydrolases of macro- 
phages (24,  25).  To secure an abundant and homogeneous 
cell source, Cohn and Wiener elicited rabbit alveolar and peri- 
toneal macrophages with BCG and with mineral oil, respec- 
tively. Then they separated the granules ofmacrophages from 
the  other  major  organelles,  especially  mitochondria,  on 
isopycnic  sucrose gradients. They proved that macrophage 
granules, like those of their polymorphonuclear cousins, are 
a particularly rich source of de Duve's lysosomes. One of Zan's 
favorite images was an early electron micrograph of the abun- 
dant lysosomes in a BCG-elicited alveolar macrophage (Fig. 3). 
When Zan followed the response of macrophage lysosomes 
to particle ingestion (25), he again observed a solubilization 
of the particulate hydrolases. Zan had the benefit of unpub- 
lished electron micrographs from his friend David Luck, who 
documented the continuity of the phagolysosomal compart- 
ment in macrophages. This was soon followed by the seminal 
micrographs of Dorothy Zucker-Franklin, who together with 
Hirsch visualized lysosome-phagosome  fusion in neutrophils. 
So Zan concluded that phagocyte granules were lysosomes 
that discharged their contents into the phagosome containing 
the ingested organism. The membranes of this phagolyso- 
some, or digestive compartment, were rupturing during cell 
homogenization, accounting for the observed solubilization 
of hydrolases during phagocytosis. 
Zan wrote of these experiments, "once a foreign substance 
has been taken into the cytoplasm of the macrophage and 
segregated within a membrane system, its fate may depend 
4  Tribute  to Zanvil Alexander  Cohn Figure  3.  An electron micrograph of a typical  BCG-induced  alveolar macrophage that shows abundant lysosomal  granules. Granules of various 
size, density,  and internal  structure  are arranged  in a rosette-like  fashion  in the perinuclear region. These  particles  vary  from a uniform  electron density 
to multivesiculated  structures and myelin  figures, x12,000 (24, Fig. 1). 
in part upon its susceptibility to macrophage enzymes. Cer- 
tain inert substances  are retained, whereas others are prob- 
ably degraded in short order.  Such storage of material may 
be reflected in the accumulation of macrophages at local sites 
such as in tuberculous and lepromatous lesions" (25). So the 
cell biology of endocytosis and host resistance  had begun, 
and reciprocally,  phagocytes occupied a central place during 
the formative years of cell biology. Here the seeds were also 
sown that certain organisms might escape digestion, a topic 
that Zan was to pursue in the context of leprosy and tubercu- 
losis  20 years later. 
The Formation of Lysosomes in Cultured Mouse 
Peritoneal Macrophages 
Zan then switched from rabbit  to mouse phagocytes, a 
change that would eventually lead to the use of the cultured 
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mouse peritoneal macrophage as a model for further pioneering 
studies in cell biology. The impetus for this switch most likely 
took place during studies described in the YaleJournat of Bi- 
ology and Medicine in 1962 (16-18). In a characteristically short 
introduction, he points out that the intradermal and intrave- 
nous routes of infection make it hard to follow the organisms, 
that are being injected in vivo. In contrast, he states, the mouse 
peritoneal cavity might provide a more suitable milieu to follow 
quantitatively both  cell-associated  and  nonassociated  or- 
ganisms, much as he and Morse had done with rabbit phago- 
cytes in vitro. He worked with staphylococci,  organisms that 
had been studied by Dubos, and verified several features  in 
vivo. Avirulent S. albus were internalized efficiently, whereas 
the lethal S.  aureus multiplied extracellularly, avoiding up- 
take, unless immune serum was added. Phagocyte mobiliza- 
tion or diapedesis  was markedly reduced when mice were 
treated with cortisone, x rays, and other blockers  of host re- Figure 4.  The differentiation  of  mouse  macrophages  in culture.  A mac- 
rophage  cultivated  in 50% serum  medium  for 48 h. A well-defined  collec- 
tion of large lysosomal  granules  is present in the periuuclear  region. A 
number  of  clear  pinocytic  vacuoles  are also apparent (arrows). ￿  (33, 
Fig. 1 a). 
sistance that Dubos had described. Zan emphasized that two 
populations of phagocytes were at work, resident macrophages 
and recruited polymorphonuclear granulocytes. A major de- 
terminant of  bacterial destruction was the availability of  phago- 
cytes in  sufficient numbers. 
Seeing that mouse peritoneal cells adhering to glass were 
a homogeneous source of competent and abundant phago- 
cytes, Zan turned his full attention to this population. In 1965, 
he published four papers with Belinda Benson in The  Journal 
of  Experimental Medicine describing the "in vitro differentia- 
tion of mononuclear phagocytes" (30-33). As was now stan- 
dard  fare  in  the  laboratory,  high  quality  phase  contrast 
microscopy spawned and/or supported virtually every experi- 
ment.  Zan noted that  macrophages from different sources 
varied enormously in their content of phase-dense granules 
and hydrolytic enzymes, and resident peritoneal macrophages 
were relatively weak in both respects. Yet he described a huge 
increase in phase-dense, perinuclear granules over several days 
in culture in glass Leighton tubes. Excellent preservation was 
afforded by the glutaraldehyde fixation regime developed by 
David  Sabatini  at  Rockefeller (30).  Zan distinguished  the 
granules from rod-like mitochondria (Fig. 4) and stained the 
former selectively with acid hydrolase cytochemistry as out- 
lined by Alex Novikoff. During culture of the macrophages, 
he also documented a marked increase in acid hydrolase ac- 
tivity. Zan used metabolic precursors and autoradiography 
to study the differentiation question (31).  He showed that 
silver grains from radiolabeled leucine and choline accumu- 
lated over the phase dense granules. These precursors and au- 
toradiography were just becoming available in cell biology, 
and the methods were being used by Lucien Caro and Palade, 
and by Luck,  in other Institute labs. 
Zan emphasized that  serum in the culture medium was 
a major and reversible inducer of granule differentiation, and 
that serum also stimulated the formation of  phase-lucent pino- 
cytic vesicles (32). After their formation at the cell periphery, 
the vesicles moved centripetally and gradually acquired the 
features of lysosomes, becoming phase dense and acid phos- 
phatase positive. Zan applied exogenous soluble tracers, notably 
colloidal gold and fluorescein-modified  proteins,  to prove that 
they would accumulate in the phase-dense granules, or lyso- 
somes (33). 
With the arrival of an electron microscope in the lab, Hirsch, 
Cohn, and Martha Fedorko provided clear views of macro- 
phage lysosomes (37) as well as their derivation (38).  Using 
colloidal gold as a tracer, they could visualize the formation 
of small pinocytic vesicles, their fusion into larger vacuoles, 
and the delivery of  colloid into lysosomes (38) (Fig. 5). Using 
acid hydrolase cytochemistry at the electron microscope level, 
they described a second input, dubbed "primary lysosomes" 
from the Golgi apparatus  (38). 
By counting pinocytic vesicles under phase contrast, Zan 
returned to his quantitative haunts.  In a set of four papers 
that would now qualify as "Brief Definitive Reports" he de- 
scribed the regulation of pinocytosis in mouse macrophages: 
the need for energy metabolism and physiologic temperature 
(39), the stimulatory role of anionic substances  (40),  and the 
induction by nucleosides and nucleotides (41) and by anticel- 
lular globulins in calf serum (42). He repeatedly emphasized 
the link between pinocytic activity and lysosome formation, 
and later, the induction of lysosomal hydrolases by phagocy- 
tosis  of digestible particles  (59). 
A  series  of films emerged from  the  Hirsch-Cohn  Lab, 
showing the formation and centripetal movement of pino- 
cytic vesicles, and their interaction with phase-dense granules. 
These films were somewhat less captivating than those that 
Hirsch made earlier to show granule discharge during micro- 
bial phagocytosis. However, Cohn's films ofpinocytosis were 
to prove more broadly relevant since they provide a lucid view 
of the formation and fate of pinocytic vesicles, a widespread 
cellular activity. The distinctive feature of macrophages was 
not simply their pinocytic activity but the number of lyso- 
somes and the large flow of contents from pinocytic vesicles 
to lysosomes. Equally important, the cultured mouse perito- 
neal macrophage was now ready to be explored by many scien- 
tists in  this and other laboratories. 
6  Tribute  to Zanvil Alexander  Cohn Figure  5.  The vacuolar system at the electron microscope  level. This macrophage was cultivated in 50% serum for 42 h and exposed to 10 #g/ml 
colloidal gold for 2 h before fixation. Particles  of gold are present in all structures of pinocytic origin. On the upper left, a string of pinocytic vesicles 
(Ves) contains gold, and one gold particle is present on the cell surface. Colloid is found in vacuoles scattered throughout  the cytoplasm (l,  fic). The 
larger dense granules (Gr) are also labeled. In contrast, the Golgi saccules and associated vesicles (Go),  as well as cisternae of the rough endoplasmic 
reticulum, are free of gold.  x 30,000 (38, Fig. 1). 
Biochemical Features of Endocytosis 
and Lysosomal Digestion 
In 1966,  Zan became a full professor and,  together with 
Hirsch,  renamed their joint laboratory Cellular Physiology 
and Immunology. The Rockefeller Institute for Medical Re- 
search had just become The Rockefeller University, and the 
program  for graduate  study was  underway. 
Several students were to make substantial contributions in 
the Hirsch-Cohn Lab. The first was Barbara Ehrenreich, who, 
with Zan, did a remarkable group of experiments that out- 
lined the basic biochemical features of the pinocytic vesicle- 
lysosome pathway. 
Ehrenreich and Cohn fed radioiodinated human serum al- 
bumin (43) and tritiated hemoglobin (47) to mouse perito- 
neal macrophages  so that  intracellular  digestion  of soluble 
proteins  could be followed.  They noted uptake  into phase 
dense granules by autoradiography.  When  they chromato- 
graphed the labeled material that was released from the cell, 
all of the label was associated with amino acids. Lysosome- 
mediated digestion  of internalized  proteins  was  complete! 
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reich surmised that the digestive capacities of living ceils had 
to be extensive, since it was clear that actively pinocytic mac- 
rophages could be cultured for many days without any vacuolar 
swelling. 
Together with another graduate fellow, Zena Werb, Zan 
studied  cholesterol  uptake  metabolism  and  distribution  in 
mouse macrophages  (69-71).  They identified  a cholesterol 
esterase with an acidic pH optimum in macrophage lysosomes. 
The enzyme was subsequently implicated by others in foam 
cell development. The contributions of macrophages to ath- 
erosclerosis  was an area that Zan very much wanted to pursue 
further. 
While lysosomes had been identified as biochemically dis- 
tinct organeUes in the 1950s, Zan's experiments in the 1960s 
put lysosomes into the dynamic context of intact cells. The 
interplay with the plasma membrane via endocytic vesicles 
was beautifully clear,  and this pathway was capable of han- 
dling substrates to an extent limited primarily by an investi- 
gator's creativity. The completeness of digestion of most in- 
ternalized substrates was established, and the input from the 
Golgi apparatus a likelihood. The distinctive potential ofmac- 
rophages  was the extent  of their  scavenging  and  digestive 
capacities,  but the endocytic pathway was now opened for 
further  experimentation  in  all  cells. 
Figure  6.  Permeability  studies of endocytic vacuoles. Following up- 
take by pinocytosis, the enzyme invertase dramatically shrinks vacuoles. 
Phase-contrast micrographs. (Tbp) Immediately  after the addition of 500 
/xg/ml of invertase. The cells had been cultivated for 24 h with 0.02 M 
sucrose and contain numerous vacuoles  that have  been swollen  by uptake 
of the impermeable  disaccharide sucrose. (Bottom) By 120 rain after inver- 
tase administration, all the large vacuoles have disappeared leaving a res- 
idue of tiny dense granules, x2,500 (57, Fig. 7, a and d). 
Ehrenreich  and Cohn pursued the thoroughness  of lyso- 
somal digestion by administering  peptides and oligosaccha- 
rides, including nonhydrolyzable D  forms. They found that 
the presence of undigested peptide or saccharide in the vacuolar 
system exerted an osmotic pressure, and the vacuoles would 
swell (57, 58). By monitoring vacuole swelling, Barbara and 
Zan could determine if the peptide or saccharide were being 
digested into permeable solutes, without the use of any ra- 
diolabels.  They showed that  most peptides and saccharides 
had to be digested to their amino acid and monosaccharide 
building blocks to avoid swelling of the vacuoles. Zan's  fa- 
vorite part  of these experiments  was the  swelling induced 
by sucrose. By feeding invertase to the macrophage, they ini- 
tiated sucrose digestion and shrinkage of the swollen vacuolar 
system (Fig.  6).  These  were some of the first  experiments 
on the permeability of intracellular  organelles. As in the studies 
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The Mononuclear Phagocyte System 
The origin of mononuclear phagocytes in situ became the 
next focus. A starting point was the paper by William Ben- 
nett and Cohn showing that blood monocytes would develop 
all of the now typical features of macrophages when placed 
in culture (36).  Similar  events had been noted years before 
at the Sir William Dunn School of Pathology in Oxford by 
Robert Ebert and Howard Florey, who observed the devel- 
opment of extravasated monocytes in  situ.  In  the  1960s  at 
the Dunn School, Alvin Volkman and James Gowans were 
also providing direct evidence for the origin of tissue macro- 
phages from blood monocytes. Zan was always fond of Oxford 
University, especially the Dunn School and its monumental 
contributions to antibiosis, experimental pathology, and cell- 
mediated immunity.  Zan was to spend a sabbatical there in 
1988  as the  Newton-Abraham  Visiting  Professor. 
With Hirsch and Ralph van Furth, Zan carried out studies 
that identified the blood monocyte as the precursor for tissue 
macrophages,  and the bone marrow as the source of mono- 
cytes, van Furth worked both in Leiden and during  several 
sabbatical visits at Rockefeller. Using [3H]thymidine labels 
newly available  from Eugene Cronkite  at Brookhaven,  van 
Furth and Cohn subjected the pathway of bone marrow to 
blood to tissues to quantitative and direct observation. They 
found that monocytes were nonproliferating cells derived from 
proliferating precursors in the marrow (53).  van Furth and 
Cohn monitored the movement of monocytes into the peri- 
toneal cavity and elicited a recruitment of new macrophages 
with various stimuli,  one being the injection of calf serum. 
Further  studies in Leiden monitored  the origin  of Kupffer 
cells,  alveolar macrophages,  and spleen macrophages.  Later, van Furth, Fedorko, and Hirsch did dectron microscope studies 
on bone marrow colonies containing precursor monoblasts 
and promonocytes, and they described production capacities 
and kinetics. 
These experiments led to a redefinition of the reticuloen- 
dothelial system (RES) (78). The well-known capacity of the 
RES to clear colloids, organisms,  and antigens could now 
be attributed to the endocytic pathway of the mononuclear 
phagocyte system. This work went beyond a new nomencla- 
ture to a redefinition based on developmental origins and cell 
biological features. Mononuclear phagocytes in other microen- 
vironments were denoted and would attract Zan's attention 
later, for example, macrophages in the lung (202, 211, 277, 
302), liver (256, 257), and spleen (328). Once cell biological 
criteria had been brought to the identification of mononuclear 
phagocytes,  the foundation was in place for the laboratory 
to pursue other distinct  cell systems, especially endothelial 
cells and dendritic cells. 
The vital interaction with van Furth also produced five 
conferences on mononuclear phagocytes, held in Leiden, that 
brought together many investigators in the expanding mac- 
rophage universe. The volumes describing the deliberations 
of these meetings, all edited by van Furth (Table 1), provide 
a detailed survey into the Zan Cohn era of macrophage bi- 
ology. Zan's honorary degree from Rikjsuniversiteit in Leiden 
in  1990 was very special to him. 
The Macrophage  Plasma Membrane 
and Membrane Recycling 
The themes of endocytosis,  lysosomes,  and the mononuclear 
phagocyte system that emerged in the 1960s are all too fa- 
miliar now. Yet in 1970, the Hirsch-Cohn Lab served as a 
rare focus for the cell biological study of host defense (82). 
A group of students and postdoctoral  investigators sought 
to work with Zan and Jim, and a flurry of new activities 
Table  1.  Leiden  Conferences  on Mononuclear Phagocytes 
Mononuclear Phagocytes 
Blackwell Scientific  Publications Ltd., Oxford, 1970 
Conference: September  2-5, 1969 
Mononuclear Phagocytes in Immunity,  Infection, and Pathology 
Blackwell Scientific  Publications Ltd., Oxford, 1975 
Conference: September  2-7, 1973 
Mononuclear Phagocytes: Functional Aspects 
Martinus Nijhoff  Publishers, The Hague, 1980 
Conference: September 17-24, 1978 
Mononuclear Phagocytes: Characteristics, Physiology and Function 
Martinus Nijhoff  Publishers, Dordrecht, 1985 
Conference: May 9-16, 1984 
Mononuclear Phagocytes: Biology of Monocytes and Macrophages 
Kluwer Academic  Publishers, Dordrecht, 1992 
Conference: May 13-16, 1991 
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emerged. The mouse peritoneal macrophage was readily ac- 
cessible, and experiments became far less burdensome when 
tissue culture plastic replaced glassware, and CO2 incubators 
replaced various gassed containers. While not evident from 
Zan's bibliography, a critical individual in the 1970s was Samuel 
Silverstein, who provided much expertise in cell biology and 
led most of the work on phagocytosis and viruses. Many in- 
dividuals enjoyed both Sam and Zan as mentors, even though 
the two had few joint publications  (83, 125, 144, 145). 
By 1970, Zan's interests in the vacuolar system shifted sub- 
stantially, from contents (acid hydrolases plus substrates cap- 
tured by endocytosis) to containers  (the plasma membrane 
and membranes of the endocytic apparatus).  This was the 
time when the first plasma membrane protein, red cell glyco- 
phorin, was being characterized by Vincent Marchesi. Two 
peroxidase enzymes proved fruitful early on. The first, lac- 
toperoxidase (LPO) entered the lab because of Zan's friend- 
ship with Seymour Klebanoff. Klebanoff studied thyroid me- 
tabolism at Rockefeller years earlier, and afterward found that 
neutrophil peroxidase, together with hydrogen peroxide, had 
microbicidal and halogenating activities. Zan always seemed 
intrigued by the fact that hydrogen peroxide, a time-honored 
antiseptic, is a substance used by phagocytes to kill microbes 
and other cells (see below). 
Challenged to develop better methods for analyzing the 
plasma membrane biochemically and functionally (114), Zan 
used LPO to attach radioiodine covalently to membrane pro- 
teins in living cells. Ann Hubbard, in graduate studies with 
Z,an, devised the relatively gentle system whereby glucose ox- 
idase and glucose were used as a source of H202.  She then 
added LPO in the cold and was able to selectively iodinate 
externally disposed polypeptides  of the plasma membrane. 
Red cells were iodinated first (75) and then L cell fibroblasts 
(102). In the latter, it became possible to document the rela- 
tively slow turnover of most plasma membrane proteins in 
cultured cells. When Hubbard and Cohn coaxed L cells to 
phagocytose latex particles, they found that the phagocytic 
vacuole membrane contained a representative sample of plasma 
membrane polypeptides, and that phagocytosis was associated 
with a much more rapid turnover of these polypeptides (103). 
Werb made similar findings on the effect of phagocytosis on 
the turnover of the plasma membrane enzyme, 5'-nucleoti- 
dase (79). 
The other peroxidase, horseradish peroxidase (HRP), was 
chosen by Ralph Steinman and Cohn because of the relative 
ease of quantitation (with the same enzymatic assay being 
used by Hubbard to standardize her LPO) and visualization 
(with the new electron microscopic diaminobenzidine method 
that had been introduced by Richard Graham and Morris 
Karnovsky).  Steinman  and Cohn used HRP to quantitate 
solute uptake into cultured macrophages (76) and fibroblasts 
(93).  The method did not require  radiolabels and  totally 
replaced the counting of pinocytic vesicles that had been used 
in so much of the earlier work. In spite of the vigorous pino- 
cytic activity of macrophages, Steinman and Cohn found the 
amounts of solute that were internalized  in the fluid phase 
to be extremely small relative to the applied load. However, 
they described  a  dramatic enhancement of uptake  when HRP-anti-HRP immune complexes were administered and 
internalized via the Fc receptor (77). 
Because internalized HRP could be visualized at the elec- 
tron microscope (EM) level, Steinman and Cohn could take 
stereologic approaches  to measure the size of the intracel- 
lular compartments that were labeled by HRP, as well as the 
kinetics with which these compartments filled. The pheno- 
menon of extensive membrane recycling during pinocytosis 
became apparent (117). They estimated that the area of mem- 
brane surrounding newly formed pinocytic vesicles  was equiva- 
lent to an influx of half the macrophage surface area every 
33 minutes. Yet they found that the volume and area of the 
compartments in which HRP solute accumulated was con- 
siderably less than the volume and area of internalized vesicles. 
They made qualitatively similar findings in L cell fibroblasts, 
the cells in which Hubbard documented a relatively slow turn- 
over of membrane proteins. They concluded that, during the 
uptake and delivery of HRP to digestive lysosomes,  there 
likely was an enormous flow and recycling of vesicle mem- 
brane into and back out of cells (117, 231). 
Graduate fellow William Muller amalgamated the LPO 
and HtLP findings to approach the recycling of membrane 
proteins directly.  This time Muller covalently linked LPO 
to latex  beads,  fed the beads  to macrophages, added glu- 
cose-glucose oxidase  to  generate hydrogen peroxide,  and 
thereby covalently linked 125I to the disposed polypeptides 
of intravacuolar membranes (157). Muller could then observe 
that membrane polypeptides that had been iodinated from 
within the cell would rapidly return to the cell surface and 
then back into the cell (158, 231). Ira Mellman used internal- 
ized soluble LPO to iodinate pinocytic vesicle membranes. 
He found that the labeled,  internal polypeptides resembled 
those on the plasma membrane (156). With the advent of 
monoclonal antibodies, specific membrane components could 
be identified on cell surface, phagosome, and pinocytic vesicle 
membranes (158, 227). Mellman documented a selective in- 
crease in the turnover of a plasma membrane receptor during 
Fc receptor-mediated phagocytosis (225). 
In the 1970s, Zan's emphasis on the plasma and vacuolar 
membranes of macrophages was far from limited to these per- 
oxidase studies. The array of approaches and topics that an- 
teceded the peroxidase work, or were studied simultaneously, 
included the behavior of macrophage membrane markers 
following the formation of macrophage-melanocyte hetero- 
karyons (63-66),  a study that provided lovely examples of 
the fluid-mosaic model of membrane structure that was being 
developed at that time by Jonathan Singer;  the uptake and 
turnover of the plasma membrane enzyme 5'-nucleotidase (79, 
112, 113); cell surface sites accessible to lectins (87, 88),  to 
antimacrophage antibodies (74),  and to modification with 
trinitrophenyl groups (140); the isolation of Fc receptor-nega- 
tive variants (150); uptake of cholesterol into macrophages 
(69-71);  and the modification of fatty acids in macrophage 
phospholipids (121, 155). Characteristically, Zan and colleagues 
carried out all of these perturbations in living ceils and with 
microscopic monitoring. 
Graduate fellows Nadia Nogueira, David Lepay, and Stephen 
Aley also applied the methods that were being used to study 
the macrophage cell surface to several microbes that were of 
great interest to the lab (below): Trypanosoma  cruzi (190, 205), 
Leishmania donovani (224),  and Entamoeba histolytica (151, 
152, 239). 
With graduate fellow Margaret Kielian,  Zan monitored 
phagosome-lysosome  fusion in macrophages (154, 184, 185). 
Perhaps of greatest interest were the anionic compounds that 
blocked fusion (203, 204). At the same time Hirsch, Silver- 
stein, and Marcus Horwitz were engaged in studies where 
intracellular microorganisms interfered with normal fusion 
events. At the time of his death, Zan was poised to identify 
compounds used by pathogenic microorganisms to establish 
their unique intravacuolar  environments, particularly viru- 
lent Mycobacterium tuberculosis. 
The Macrophage  as a  Secretory Cell 
Z.an, together with  a  former graduate fellow,  Siamon 
Gordon, uncovered the profound secretory function of mac- 
rophages. The array of secretory products were to prove ex- 
traordinarily diverse. Macrophages not only used the tradi- 
tional pathway of protein secretion via the rough endoplasmic 
reticulum but also released other products via enzymes of 
respiration and arachidonic acid metabolism that were as- 
sociated with the plasma membrane. 
The first evidence involved lysozyme (89). Prior work had 
shown that lysozyme, a granule-associated muramidase in neu- 
trophils, could be regurgitated acutely during phagocytosis. 
Elliot Osserman had found a huge output of lysozyme in 
the urine of patients with monocytic leukemia. Gordon and 
Cohn, searching for differentiation markers for macrophages 
to be used in their somatic cell genetic studies (63-66),  noted 
that many different populations of macrophages released lyso- 
zyme continously for days and without a phagocytic chal- 
lenge. The secretion rate amounted to 2.5% of total cell pro- 
tein per day. Then, plasminogen activator (fibrinolytic activity 
in the presence of plasmin) was studied and found to be secreted 
copiously by thioglycollate-elicited, but not resident, mac- 
rophages. Gordon and colleagues found that, unlike the situ- 
ation with lysozyme, plasminogen activator release was in- 
ducible and proceeded in a two-step fashion that was to become 
standard for many subsequent macrophage activities. The cells 
first were primed with LPS and then provoked with a phago- 
cytic meal (90). Another important subsequent finding was 
that the fibrinolytic pathway could be primed during T cell- 
mediated immunity in situ (129). 
Zan and colleagues,  especially Carl Nathan, then turned 
to metabolites of oxygen, another class of products that mac- 
rophages can release (130, 142, 144-146, 160, 183). They noted 
differences in superoxide and hydrogen peroxide output from 
macrophages elicited by distinct inflammatory and immune 
stimuli. They  associated these differences with changes in 
macrophage-mediated microbial and tumor killing (see  below). 
William Scott and Cohn uncovered and pursued a third 
class ofmacrophage secretions, arachidonic acid metabolites. 
Again, a major contribution was made by a graduate fellow, 
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rated arachidonic acid (20:4) constituted a major fraction (25%) 
of the fatty acids  of macrophage phospholipids.  The latter 
could be substituted close to equilibrium by an overnight cul- 
ture in [3H]arachidonic acid, thereby allowing the group to 
quantitate subsequent metabolism by the cyclooxygenase  and 
lipooxygenase pathways. By high performance liquid chro- 
matography (HPLC), they were able to identify many of the 
20:4  products released from macrophages. 
Scott, Cohn, and colleagues showed that the macrophage 
was in fact a major cellular source of several arachidonic acid 
metabolites, many of which were known to have major effects 
in inflammation and on smooth muscle and vascular tone. 
They found that in resident macrophages, particle uptake trig- 
gered the secretion of large amounts of prostaglandins, both 
PGE and PGFlol (170). Strikingly, they also proved that mac- 
rophages were an active source of the elusive leukotriene C 
(LTC)  (169,  170).  This glutathione-lipid adduct was other- 
wise known as one of the trace "slow reacting substances" 
that cause spasms of airway smooth muscle. They noted that 
mouse pulmonary macrophages synthesized leukotrienes C, 
D, and E (211), while human alveolar macrophages made sub- 
stantial  amounts  of the chemotactic agent  leukotriene B4 
(202).  Rouzer, Scott, and Cohn discovered that the release 
of LTC from macrophages could be triggered by IgE-anti- 
IgE complexes (210, 212),  a remarkable finding considering 
the prior emphasis that IgE immune complexes worked pri- 
marily on mast cells. Rouzer could block LTC metabolism 
selectively by applying buthionine sulfoximine, an inhibitor 
of glutathione synthesis (193, 209). Finally the group described 
that  macrophages could utilize exogenous 20:4  and other 
precursors to rapidly synthesize prostacyclin and hydroxyei- 
cosatetraenoic acids (214). Interestingly, arachidonic acid me- 
tabolism was one of the few macrophage activities to be down- 
regulated in otherwise "activated" cells (215). This could occur 
locally within restricted tissue environments (277). 
Within a period of 15 years, Zan had created a vigorous 
environment that was attractive to graduate students, post- 
doctoral fellows, junior faculty, and sabbatical  visitors.  This 
in turn led to the development of three major avenues of mac- 
rophage biology, each with substantial impact on the broader 
areas  of cell and immunobiology:  the pinocytic-lysosome 
pathway, the mononuclear phagocyte in vivo, and several secre- 
tory roles. The function of the macrophage had changed from 
a "big eater" to the "versatile element of inflammation" (221). 
These avenues of macrophage function provided the under- 
pinnings for several new areas (see below) that would emerge 
and that directly pertained to Zan's interests in host defense 
mechanisms. 
required as accessories  by the immunologically  competent lym- 
phocytes. Early on, the function of the macrophage was per- 
plexing.  Zan's experiments on the distribution  and fate of 
protein antigens in peritoneal macrophages showed that these 
were thoroughly degraded (43, 47, 57, 58) but failed to identify 
a postulated reservoir of intact protein on the macrophage 
cell surface (76,  77).  Patrick Chen and Hirsch found that en- 
riched populations of peritoneal macrophages could exert two 
effects on the antibody response. One was an enhancing effect 
at low doses of macrophages, but this was primarily at the 
level of lymphocyte viability and could be bypassed by adding 
2-mercaptoethanol. A second was a strongly inhibitory func- 
tion that was evident at doses corresponding to just 2-3% 
of the cultured cells.  At  the time,  some papers  concluded 
that the function of macrophages was MHC restricted, while 
others concluded otherwise. 
Steinman and Cohn switched from peritoneal cells to spleen 
cells to understand the induction of immune responses in a 
major lymphoid organ of the mouse. They encountered an 
irregularly shaped population of cells, named "dendritic cells" 
(84).  In spite of years of experience with macrophages from 
many tissues  and species, neither Cohn nor Hirsch had ever 
seen a phagocyte that resembled these dendritic cells in terms 
of organelles (Fig.  7) and motility. At that time, there was 
extensive experience in the lab  with  the differentiated fea- 
tures of phagocytes. Michel Rabinovitch had pursued in some 
detail the.abundance and phagocytic role of Fc receptors in 
macrophages.  Hirsch and graduate fellow Sally Zigmond were 
Discovery  of Dendritic  Cells 
In 1966 the first success at inducing primary antibody re- 
sponses was reported by Robert Mishell and Richard Dutton 
in mouse spleen cell suspensions. Donald Rowley and Donald 
Mosier found that plastic adherent cells, presumably macro- 
phages (there were few other alternatives at the time), were 
Figure 7.  Distinguishing  macrophages  and dendritic  cells  by differences 
in lysosomal  content. Phase-contrast  (top) and bright-field  micrographs 
(bottom) after staining for lysosomal  acid phosphatase. The macrophage 
(note  ruffles,  vesicles,  refractile  inclusions)  exhibits  considerable  acid  phos- 
phatase in a perinuclear  position. The dendritic  cell has a few small  reac- 
tive granules  close  to the nucleus  (arrows). x2,700 (84, Fig. 4, a and b). 
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and Cohn were utilizing several phagocyte differentiation 
markers  in  their  macrophage-melanocyte fusion  studies 
(63-66). When Steinman and Cohn evaluated this repertoire 
of known macrophage traits in dendritic cells, not a single 
resemblance to macrophages was apparent (91, 92). Dendritic 
cells lacked the abundant membrane ATPase and acid phos- 
phatase that were typical of macrophages; the cells had little 
phagocytic activity in culture and in vivo; the dendritic cells 
detached from culture surfaces and had poor viability; their 
turnover in spleen was rapid; and in situ, dendritic cells were 
primarily localized to the white pulp instead of the red pulp 
(105). Soon the group noted the juxtaposition of dendritic 
cells with developing antibody-forming cells (106), but the 
turning point was a method to prepare enriched populations 
of dendritic cells and macrophages, both trace populations 
in mouse spleen suspensions (148). To do so, Steinman took 
advantage of the fact that dendritic cells lacked Fc receptors. 
Cohn, Steinman, and graduate fellow Michel Nussenzweig 
then documented dramatic differences between the two cell 
types in MHC class II expression (148), surface markers (192), 
and T cell stimulatory function (166). The findings in mouse 
spleen were evident in other tissues and species, including 
human blood,  as  studied by graduate fellow Wesley Van 
Voorhis (232).  Dendritic cells therefore represented a new 
leukocyte distinct in morphology, phenotype, and function 
from phagocytes and lymphocytes. Mechanisms underlying 
the induction of primary immune responses by dendritic cells 
in vitro and in vivo were now accessible. 
Zan played another role in uncovering the dendritic cell 
system, one typical of other research areas in the lab. Fre- 
quently invited to organize meetings on mononuclear phago- 
cytes, Zan helped organize a symposium in Japan in 1980. 
Meetings engender new collaborations, in this case a long- 
standing effort with Kayo Inaba in Kyoto, which was to prove 
essential  to the characterization of dendritic cells. 
Macrophage Activation:  Antimicrobial 
and Antitumor Activities 
Zan's early work focused on the "constitutive" microbi- 
cidal activities  of phagocytes, but he often wrote in reviews 
about their "acquired" kiUing capacities. The concept of quali- 
tative changes in macrophage antimicrobial function was pi- 
oneered by scientists at the Trudeau Institute, where Zan was 
a longtime advisor and trustee. George Mackaness, who had 
been a member of the Dubos-Hirsch Lab in the late 1950s, 
found that the microbicidal activity of macrophages increased 
during murine listeriosis  and tuberculosis. Robert  North 
provided evidence that both thymus-dependent lymphocytes 
and newly recruited macrophages were critical for resistance 
in vivo. 
In the mid 1970s, the activation of peritoneal macrophage 
function took center stage, if such a thing were possible in 
Zan's lab! Zan emphasized that "activation" was a qualitative 
or quantitative increase in discrete, measurable functions rel- 
ative to the baseline in resident peritoneal macrophages (126). 
Zan and colleagues  studied many properties, and typically 
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in a number of populations elicited by different stimuli. Some 
changes included an increase in pinocytic activity (100) and 
turnover of the ectoenzyme 5'-nucleotidase (112) with Paul 
Edelson; enhanced production of plasminogen activator with 
Gordon (129), Jay Unkeless,  and Edward Reich; enhanced 
release of superoxide anion (130, 183) with Richard John- 
ston; increased spreading (110, 138, 139) with Celso Bianco 
and Otto G6tze; and altered plasma membrane composition 
and turnover (173) with Helen Yin. 
However, most investigators in the field considered the pin- 
nacle of activation to be enhanced antimicrobial and antitumor 
activity.  Zan and colleagues encountered such capacities in 
macrophages taken from mice infected with viable BCG and 
T. cruzi. Zan considered the studies on T. cruzi, initiated with 
graduate fellow Nadia Nogueira, to be a high point. This 
obligate intracellular protozoan parasite causes Chagas' dis- 
ease in humans. First  they attended to the organism itself 
and learned to isolate the pathogenic trypomastigote form 
(104). Remarkably, when they followed the uptake and in- 
tracellular fate of cultured trypomastigotes,  they observed that 
parasites escaped from the uptake vacuole and grew in the 
cytoplasm (115). However, in macrophages that were taken 
from mice that had been infected with either T. cruzi or BCG, 
and then challenged with the corresponding specific antigen 
(so-called "immune-boosted" macrophages), Nogueira and 
Cohn noted killing in 75% of the internalized parasites (123). 
When a lymphokine-rich conditioned medium was produced 
by spleen cells from infected mice and applied to otherwise 
nonresistant phagocytes in vitro, the group induced sterilizing 
resistance and other parameters of macrophage activation (Fig. 
8) (124, 131). They made similar findings with human mono- 
cytes (207). Whereas prior studies with other organisms had 
produced bacteriostasis and/or short-lived cidal effects, Zan's 
T. cruzi work provided the precedent that products of im- 
munologically active spleen or blood cells could change the 
macrophage from a susceptible  to a sterilizing cell. 
Henry Murray proceeded to analyze another obligate in- 
tracellular protozoan that was readily visualized,  Toxoplasma 
gondii. This was familiar territory because of earlier studies 
by Thomas  Jones and Hirsch in the lab. This class of organisms 
again allowed one to monitor microbial fate directly by mi- 
croscopy and to ensure that microbicidal effects were occur- 
ring within the cell and not extraceUularly. Murray and Cohn 
proceeded to outline the sensitivity of T. gondii to hydrogen 
peroxide (141), the capacity of scavengers of oxygen metabo- 
lites to block killing by immune-boosted macrophages (142, 
161) (Fig. 9), and the tight correlation between enhanced ox- 
idative  metabolism and killing (160). 
The work was then taken into the realm of tumor resis- 
tance by Carl Nathan, who had previously discovered with 
Richard Root that appropriately activated macrophages could 
produce as much hydrogen peroxide as polys. Along with 
Silverstein, the group now demonstrated extracellular, hydro- 
gen peroxide-dependent killing following the triggering with 
pharmacologic agents (144, 145) and antibody-coated tumor 
cells (162, 163). Tumor cell killing was manifest only in ap- 
propriately activated macrophages, especially those obtained 
from BCG- and C. parvum-primed mice. Tumor cell antiox- Figure  9.  Phase  contrast micrographs of  macrophages 24 h after  infec- 
tion with T. gondii. (Top) Inhibition of toxoplasma replication by normal 
macrophages cultivated 18 h before  infection in heart infusion broth (8 
mg/ml) and 5% toxoplasma  lymphokine. Only a few organisms are seen 
(arrows). (Bottom) Same macrophages after exposure  to exogenous  catalase 
(2 mg/ml) showing  growth of toxoplasma  (arrows). x 1,200 (160, Fig. 8). 
Figure  8.  Phase-contrast  micrographs of proteose  peptone-induced  mac- 
rophages 72 h after infection  with T. cruzi. (Top) Cells  cultivated  in medium 
alone for the whole  time. Many  of the macrophages are parasitized (arrow). 
(Bottom) Cells  cultivated  in medium  containing 25% of  BCG-induced  spleen 
cell factor. The burden of protozoa has been reduced by the lymphokine 
treatment,  x600 (131, Fig. 4). 
idant  defenses could be compromised  in vitro and in vivo 
(164,  188,  199,  220, 252),  and this led to enhanced killing. 
In other interesting experiments, the group induced killing 
of targets, by applying peroxidase and a halide to cells (81), 
and sensitized organisms with peroxidase to small amounts 
of H202 (206). Therefore, Zan and a talented group of clin- 
icaUy trained individuals  helped expand the long-standing topic 
of macrophage activation during T  cell-mediated immunity 
to several important  targets and to concrete ideas on mech- 
anism. 
Cytotoxicity Mediated by Pore-forming Proteins 
Studies on the biochemical basis for cell-mediated cyto- 
toxicity were extended to other systems with John Ding-E 
Young, first a graduate fellow and then faculty member. Young 
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and Cohn emphasized killing by cytolytic lymphocytes, both 
T  and NK cells.  The paradigm proved to be different from 
the macrophage.  They showed that,  instead of oxygen me- 
tabolites, killer cells released a pore-forming protein by granule- 
mediated exocytosis. Young isolated from killer cell granules 
this "perforin" (260, 285, 291), as well as two serine esterases 
(294). Young characterized the lesions that were created by 
perforin deposition in targets as large ion-carrying pores and 
visualized the pores by electron microscopy (292). He found 
these functional properties of perforin to be similar  to the 
terminal complex of the complement cascade,  to which per- 
forin was found to have other homologies (296, 298). Young 
and colleagues found that  the release  of perforin  could be 
induced by ionophores (299). They further identified a cal- 
cium and perforin-independent killing pathway (316) and pur- 
sued other cytolytic factors and cell types such as eosinophils 
(289), mast cells (312),  and the agent of amoebic dysentery, 
Entamoeba  histolytica  (219,  262). 
Macrophage  Signaling via a Major Substrate 
of Protein Kinase C  (PKC) 
The lab directed its early efforts in the signaling  arena to 
the prototypic Fc  3, receptor, which is pivotal in triggering 
macrophage phagocytic and secretory functions. Mellman and 
Unkeless had purified the receptor some years earlier.  Young found that FcR triggering could depolarize macrophages (235) 
and induce ion fluxes (264), including an increase in intracel- 
lular calcium (250). Scott and colleagues  showed that the secre- 
tion of arachidonic acid metabolites only required attachment 
of an antibody-coated particle to surface Fc receptors (168). 
With the arrival of Alan Aderem, the study of signal trans- 
duction for enhanced arachidonic acid, or 20:4, metabolism 
continued (238, 251), but an important change was to em- 
phasize one of Zan's favorite stimuli for enhanced macrophage 
function (10, 17), namely the lipopolysaccharide (LPS) from 
the cell walls of Gram-negative organisms. 
Aderem defined sequential signals for the induction of 20:4 
metabolism by LPS. LPS would first prime the macrophages, 
and then the cells could be provoked with such triggers as 
PMA, latex particles, or calcium ionophore (271, 273, 319). 
Aderem decided to pursue the mechanism of LPS function 
at the level of protein myristoylation and noted specific LPS- 
primed species (272). He proved that a species that migrated 
with an apparent molecular mass of 68 kilodaltons (kD) was 
a major substrate of PKC (318) and was later termed myristoy- 
lated alanine-rich  C-ldnase substrate (MARCKS). LPS-induced 
myristoylation targeted MAR.CKS to membranes,  permit- 
ting access to PKC.  Aderem soon defined the capacity of 
MARCKS to interact with actin. The group described how 
interferon 3, (IFN-"r'), the prototype activator of macrophage 
function, induced the myristoylation of a distinct 48-kD mac- 
rophage protein (320). Although the link to 20:4 metabo- 
lism remained unspecified, Zan was at last seeing connections 
being unravelled between LPS and IFN-3',  the macrophage 
surface, and the cytoskeleton. 
Endothelial Transmigration or Monocyte 
Diapedesis 
Zan always emphasized in reviews the need to understand 
the  recruitment of monocytes from the blood  stream,  a 
phenomenon that  underlies  so  many contexts,  including 
delayed-type hypersensitivity  (DTH), granuloma formation 
in chronic infectious diseases, and perhaps atherosclerosis. Eva 
Cramer, Nicholas Pawlowski, and Scott were the first to ap- 
proach endothelial cells in the lab. They found that the mac- 
rophage product leukotriene C could stimulate prostacyclin 
synthesis by endothelial  cells (222) as well as the transen- 
dothelial migration of neutrophils (242). Patricia Detmers, 
Marco Baggiolini,  and Zan showed that interleukin-8 (IL-8) 
could activate the integrins  of neutrophils and enhance the 
binding of polys to endothelial cells (349, 354). Zan and col- 
leagues then identified an experimental model in which human 
blood monocytes selectively  bound and transmigrated through 
the  junctional complexes of human endothelium (259,329). 
The exploration of the molecular basis for monocyte trans- 
migration became feasible when Muller rejoined the lab to 
set up a vascular biology unit. He rendered the tissue culture 
model appropriate for quantitative studies and also developed 
a monoclonal antibody to an antigen that was abundant in 
endothelial  junctions  (344). Later  identified  as  platelet/ 
endothelial cell adhesion molecule 1 (PECAM-1), this proved 
to be the first molecular species that both localizes to en- 
dothelial junctions and is required for monocyte diapedesis. 
Manipulating  Cell-mediated Immunity with 
Lymphokines in Human Infectious Disease 
Early in the 1980s, Zan was at last ready to study macro- 
phage function directly in the setting of human infectious 
disease. With Gilla Kaplan, he initiated a program to study 
leprosy and established collaborations in Colombia,  Brazil, 
India, Nepal, Ethiopia, and the Philippines. Suitcases packed 
with supplies for experiments became part of the lab envi- 
ronment. 
Cohn and Kaplan chose leprosy for many reasons. Clini- 
cally, it remains a major scourge. Experimentally, much of 
the critical pathology is accessible in the skin. Biologically, 
the mechanisms underlying the spectrum from lepromatous 
to tuberculoid poles of the disease were pertinent to the lab's 
interests.  Lepromatous  leprosy was in essence an antigen- 
specific immunodeficiency expressed in the form of a microbi- 
ally permissive macrophage, while tuberculoid disease and 
some reactional states were manifestations of heightened T 
cell immunity. So the time had come. Zan always looked for- 
ward to bringing his experiments into the realm of human 
disease, and he understood the reciprocal but too often for- 
gotten principle that the study of disease stimulates new in- 
sights. 
The immunologic changes in leprosy previously had been 
analyzed at the level of blood cells. Zan and colleagues fo- 
cused on the skin lesions. Graduate fellow Van Voorhis noted 
that the tymphocytes in skin infiltrates were not a represen- 
tative sample of those in blood. CD4 § T cells predominated 
at the tuberculoid pole, while a scant CD8 + infiltrate char- 
acterized the lepromatous pole (218). A demanding series of 
electron micrographs  outlined the intravacuolar location of 
Mycobacterium leprae in macrophages in lepromatous disease, 
and the presence of what appeared to be activated lympho- 
cytes at the tuberculoid pole (223). The group made com- 
parable findings in examining leishmaniasis, especially in the 
mouse model. They noted that the makeup of infectious loci 
in cutaneous and visceral infections reflected the efficacy of 
the local immune response rather than a general sample of 
blood cells (307, 327). 
In studies of blood cells from lepromatous leprosy patients, 
Zan and colleagues outlined a deficiency in the production 
of IFN-3~ and macrophage-activating  cytokines following chal- 
lenge with M. teprae antigens (228, 243). When they found 
that low levels of responsiveness in T  cells from some pa- 
tients could be boosted by interleukin 2 (IL-2) (254), they 
turned to reversing the deficit in situ. Two approaches were 
taken and both proved fruitful. One was to inject purified 
protein derivative (PPD),  i.e., antigens from M.  tuberculosis. 
Although  lepromatous  patients  are  unresponsive  to  the 
lepromin antigen from M.  leprae, the patients can exhibit a 
typical DTH response to the tuberculin skin test antigens 
from M. tuberculosis (325). Kaplan, Cohn, and colleagues  noted 
a substantial decrease  in acid fast bacilli at the DTH site (326). 
So the chronically parasitized disease site did not behave as 
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literature as a result of tissue culture studies.  Instead, the dis- 
ease site had the potential to respond, and relatively rapidly. 
The second approach was classically simple and was initi- 
ated by Cohn,  Nogueira, and Nathan. Why not inject the 
T cell products, which lepromatous patients could not make 
in response to M.  leprae antigens, directly into the skin and 
observe the consequences? These products had just become 
available as a result of recombinant DNA technology. IFN-3/ 
was tested first (287) and found to replay certain features of 
DTH. Multiple injections of IFN-3, led to more pronounced 
clearance of acid-fast  bacilli  (304,  339). 
IL-2 was tested next. Kaplan and Cohn found that remark- 
ably, this lymphokine marshaled all the cellular changes that 
typified standard, antigen-elicited, DTH reactions,  only faster 
(338).  Monocytes and T  cells selectively emigrated into the 
injection site, which became classically raised and indurated 
within a day (Fig. 10). Parasitized macrophages became difficult 
to identify by electron microscopy, dendritic cells accumu- 
lated  intradermally,  and  the overlying epidermis changed 
Figure  10.  T cell  accumulation  during  the response  to intradermal  IL-2. 
Histologic (hematoxylin  and eosin) (a) and immunohistologic  staining  of 
sections with mAbs that recognize  all T cells (CD5) (Leu-1) (b and c). 
Biopsies were taken 96 h after I1.-2 injections (2 x  10 #g). At this early 
time, the majority  oft cells are of the CD4 + subset, xl00 (a); xS0 (b); 
and  x 200 (c) (338, Fig. 3). 
markedly (see below). So again, local M. leprae were not as- 
sociated with nonspecific suppression of the many cellular 
responses to IL-2 or to PPD (337). In human cutaneous leish- 
maniasis, IL-2 injections also brought about a local decrease 
in parasite numbers (347). 
Kaplan and colleagues then found that chronic, local in- 
jections of IL-2 had systemic effects as well. There were de- 
creased bacillary numbers in slit smear preparations from the 
ear (357), and increased killer cells (336,  355) and responses 
to proliferative stimuli (348)  in blood. 
These experiments with relatively low doses of intracu- 
taneous IL-2 were seminal in three respects.  First,  the ob- 
served responses to  IL-2 provided a mechanism whereby a 
local response by antigen-specific T  cells in DTH marshals 
the characteristic histologic response. Second, the response 
to IL-2 and to PPD unveiled changes in the keratinocytes that 
immediately caught the attention of Kaplan and Cohn (284). 
There was a marked and rapid keratinocyte hyperplasia, as 
well as an increase in expression of two molecules, MHC 
class II and a cytokine termed "y interferon-induced protein 
(3~-IP-10) that had been discovered by graduate fellow An- 
drew Luster, Unkeless, and Jeffrey Ravetch. When the effects 
of cytokines on keratinocyte growth were studied in vitro, 
GM-CSF but not IL-2 was noted to be stimulatory (324). 
So IL-2 injections in situ seemed to be enhancing local release 
of IFN-T and GM-CSF.  Kaplan and Cohn therefore tested 
GM-CSF directly and uncovered striking increases  in den- 
dritic cell numbers and in the rate of wound healing (364). 
Third, the systemic enhancing effects of ILo2 suggested that 
chronic low-dose intracutaneous IL-2 might be used therapeu- 
tically  in  T  cell  deficiency states,  much  like  chronic  in- 
tracutaneous insulin is used in diabetics, Zan argued. These 
sets  of findings that  emerged by direct observation of the 
IL-2 injection site in leprosy are noteworthy when compared 
with the toxicity and limited efficacy in other studies with 
high dose,  intravenous IL-2. 
As the leprosy work progressed in the 1980s, Zan and col- 
leagues naturally transferred attention to two major diseases 
in which the causative agent exhibits a tropism for macro- 
phages, AIDS (322) and tuberculosis (368). Several clinically 
trained individuals joined the lab to study white cell func- 
tion in HIV-1- infected patients. They documented the prolifer- 
ative potential of CD4 + T cells (340) and the HIV-1 burden 
in monocytes (358). Patient studies also were begun to evaluate 
the effects of intracutaneous IL-2. While  II,-2 had proven 
ineffective  in prior work, the use of high doses and the intra- 
venous route could have been compromising. The first studies 
with Juliana McElrath and Hedy Teppler encouraged Zan. 
They found that the immunocompromised, HIV-l-infected 
individual could mobilize a typical cell-mediated reaction to 
IL-2 in the skin (350)  and would show systemic effects such 
as a boost in IL-2-responsive  killer cells (369,  370).  A pro- 
gram to enhance the immune system of immunocompromised 
individuals was therefore underway. 
More recently, a program in tuberculosis began under the 
direction of Kaplan.  In  one  set  of experiments,  Anthony 
Molloy, the last graduate fellow to work with Zan, carefully 
monitored the features of human monocytes that were sup- 
15  The Editors porting the growth of BCG mycobacteria. Another set of 
experiments was based on an outgrowth of the leprosy work, 
the observation that thalidomide could decrease the produc- 
tion of TNF in patients with erythema nodosum leprosum 
and in stimulated cultures of human monocytes (361). At 
his death, Zan was organizing an expanded and multifaceted 
program in tuberculosis research and was pursuing the prom- 
ising initial  studies in wound healing and HIV-1 infection 
(above). For each of these efforts, The Rockefeller Univer- 
sity Hospital was as critical a part of the Laboratory as when 
Zan arrived to work with Dubos and Hirsch 35 years earlier. 
The Esprit of a Physician-Scientlst 
Zan's professional activities extended to many other spheres 
of academic medicine.  He played significant editorial roles 
for many journals, not just this one. He was an advisor to 
several institutions: Bates College, where he received a B.A. 
in  1948; Harvard Medical  School  and  the Massachusetts 
General Hospital,  where he received his medical education 
from 1949 to 1955; the Trudeau Institute; Roswell Park Cancer 
Institute; the New York Blood Center; and the National In- 
stitutes of Health. Together with Jim Hirsch and Alexander 
Beam, Zan organized, with Cornell University Medical Col- 
lege, one of the first medical scientist training programs for 
the combined M.D.-Ph.D. degree. Also, Zan vigorously sup- 
ported The Rockefeller University Graduate Program from 
its inception, contributing to the professional development 
of numerous graduates. Ph.D.  students are coauthors  of 80 
of his 370 publications,  and their postdoctoral  work is fea- 
tured in dozens more. Zan's leadership of the laboratory was 
strengthened by his gifted assistant,  Mrs.  Grace Silvestri. 
Two professional concerns were foremost for Zan. One was 
The Rockefeller University Hospital.  Zan regarded himself 
as a "physician-scientist"  who was most challenged by the 
biological venue of human disease. In his last 10 years, Zan 
was fully occupied by leprosy, AIDS, and tuberculosis, and 
the Hospital's  in- and out-patient facilities were vital to his 
bench observations. Zan stressed that the Hospital  served as 
the focal point for many of the finest accomplishments by 
Rockefeller investigators, whether their training was Ph.D., 
M.D., or both. This was more than happenstance. Problems 
of human disease remain intrinsically  of great interest  and 
challenging complexity,  and appropriate  animal models are 
often not available for many major illnesses. Zan therefore 
enthusiastically  assumed the position of Vice President for 
Medical Affairs in early 1992. Together with Physician-in- 
Chief  Jules Hirsch, he was energizing a successful  new Clinical 
Scholar Program for research in human disease, particularly 
the eight major conditions that currently are the Hospital's 
core. 
The other focus for Zan was his editorial responsibility 
toward this Journal. The board meets weekly to discuss the 
submitted articles and the referees' reports.  The editors of 
any journal face demanding responsibilities, but the weekly 
Journal meeting in a special way distributes the demands, pro- 
vides a time to learn and to be with colleagues, and improves 
on fairness and consistency. Zan insisted that these pages be 
the place to describe the newest developments, and that there 
be sufficient space to document conclusions adequately and 
to pursue mechanisms in detail. Over the years it has become 
more difficult  to publish  the extensive work-ups that ex- 
emplified Zan's early papers. Yet the Journal still looks for 
the qualities that made Zaffs work so substantial and enduring: 
novelty, clarity, and a mechanistic analysis that is quantita- 
tive, direct,  and multifaceted. 
Zan's personal qualities, of  which the editors were so fond, 
were familiar to many. A quiet gentleman, he was known 
for his brevity, wit, modesty, and fairness. He was quick to 
share his broad  experience and insight.  Professionally, his 
greatest pleasures were the exploits of young people, and his 
greatest concerns were for the integrity and support of  univer- 
sity life. He loved the sea and its wildlife, and he shared many 
personal interests  with  his wife Fern,  his  son David,  his 
daughter Ellen, and numerous friends. 
Zanvil Cohn was recognized in Leiden as "the founder of 
modern research on macrophages" His alma mater, Bates Col- 
lege, honored him for "his intellectual courage to explore 
the worlds of living cells, and for his quiet contributions of 
knowledge which may heal the sick" His  scientific legacy 
extends deeply into cell biology, immunology, and infectious 
disease. To The Rockefeller University and the Laboratory 
of Cellular  Physiology and Immunology, he was a warm, 
sensitive colleague who nurtured an array of scientific  findings 
and who mentored the careers of dozens of individuals. To 
the editors of The Journal of  Experimental Medicine, he upheld 
and fostered a tradition of innovation and depth, helping to 
guide the growth and international  excellence that embrace 
our profession.  We all miss this prince of a man. 
Ralph M. Steinman and Carol L. Moberg 
For the Editors 
Several individuals helped with this tribute:  Maclyn McCarty, Ralph van Furth, Samuel Silver- 
stein, Siamon Gordon, Carl Nathan, Gilla Kaplan, Ira Mellman, William Muller, Nina Bhardwaj, 
Joan Muller, Judy Adams, and William Swiggard. 
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